Retinoid therapy restores eye-specific cortical responses in adult mice with retinal degeneration

Curr Biol. 2022 Oct 24;32(20):4538-4546.e5. doi: 10.1016/j.cub.2022.09.005. Epub 2022 Sep 23.

Abstract

Despite the recent emergence of multiple cellular and molecular strategies to restore vision in retinal disorders, it remains unclear to what extent central visual circuits can recover when retinal defects are corrected in adulthood. We addressed this question in an Lrat-/- mouse model of Leber congenital amaurosis (LCA) in which retinal light sensitivity and optomotor responses are partially restored by 9-cis-retinyl acetate administration in adulthood. Following treatment, two-photon calcium imaging revealed increases in the number and response amplitude of visually responsive neurons in the primary visual cortex (V1). In particular, retinoid treatment enhanced responses from the ipsilateral eye, restoring the normal balance of eye-specific responses in V1. Additionally, the treatment rescued the modulation of cortical responses by arousal. These findings illustrate the significant plasticity of the adult central visual system and underscore the therapeutic potential of retinoid administration for adults with retinal diseases.

Keywords: 9-cis-retinyl acetate; Leber congenital amaurosis; Lrat; V1; binocularity; childhood blindness; retinal degeneration; retinal disease; retinoid treatment; two-photon calcium imaging.

MeSH terms

  • Animals
  • Calcium
  • Eye Proteins
  • Mice
  • Retina
  • Retinal Degeneration* / drug therapy
  • Retinoids / pharmacology
  • Retinoids / therapeutic use
  • cis-trans-Isomerases

Substances

  • Retinoids
  • cis-trans-Isomerases
  • Calcium
  • Eye Proteins